5-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-2-[3-[(3S)-3-propan-2-ylpiperazin-1-yl]-1,2,4-triazin-6-yl]phenol
C19H21F2N7OS — CID 156887655
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-2-[3-[(3S)-3-propan-2-ylpiperazin-1-yl]-1,2,4-triazin-6-yl]phenol
5-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-2-[3-[(3S)-3-propan-2-ylpiperazin-1-yl]-1,2,4-triazin-6-yl]phenol (PubChem CID 156887655) has the molecular formula C19H21F2N7OS and a molecular weight of 433.49 g/mol. Its IUPAC name is 5-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-2-[3-[(3S)-3-propan-2-ylpiperazin-1-yl]-1,2,4-triazin-6-yl]phenol.
Molecular Properties
| Compound Name | 5-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-2-[3-[(3S)-3-propan-2-ylpiperazin-1-yl]-1,2,4-triazin-6-yl]phenol |
|---|---|
| PubChem CID | 156887655 |
| Molecular Formula | C19H21F2N7OS |
| Molecular Weight | 433.49 g/mol |
| Exact Mass | 433.15 |
| IUPAC Name | 5-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-2-[3-[(3S)-3-propan-2-ylpiperazin-1-yl]-1,2,4-triazin-6-yl]phenol |
| SMILES | CC(C)[C@H]1CN(c2ncc(-c3ccc(-c4nnc(C(F)F)s4)cc3O)nn2)CCN1 |
| InChI | InChI=1S/C19H21F2N7OS/c1-10(2)14-9-28(6-5-22-14)19-23-8-13(24-27-19)12-4-3-11(7-15(12)29)17-25-26-18(30-17)16(20)21/h3-4,7-8,10,14,16,22,29H,5-6,9H2,1-2H3/t14-/m1/s1 |
| InChIKey | ZJQAQBVZIPPTCZ-CQSZACIVSA-N |
| XLogP | 3.13 |
| TPSA | 99.95 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 433.49 |
| LogP ≤ 5 | 3.13 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156887655 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.